Results 101 to 110 of about 79,383 (256)
Current and emerging therapies for pulmonary tuberculosis in adults
BMJ MedicineTuberculosis remains the biggest global killer from infectious causes, with an estimated 1.25 million deaths per year. The quadruple drug regimen of rifampicin, isoniazid, pyrazinamide, and ethambutol has been standard therapy for 40 years, with good ...
Michael Hunter +5 more
doaj +1 more source
Automating Sustainability: How Climate Action Unlocks the ESG Potential of Industrial Robotics
Business Strategy and the Environment, EarlyView.ABSTRACT The convergence of Industry 4.0 and global sustainability goals presents a critical paradox: while automation drives efficiency, its net impact on comprehensive environmental, social, and governance (ESG) performance remains contested. This study investigates the relationship between industrial robot and country‐level ESG performance across 63
Brahim Bergougui
wiley +1 more source
Out of Sight, Out of Mind: Digitalization's Double Role in Driving Sustainable Transition
Business Strategy and the Environment, EarlyView.ABSTRACT This paper investigates the role of digitalization in overcoming organizational barriers to sustainability. Drawing on the attention‐based view (ABV) theory, the study examines how digitalization, as a contextual condition, shapes the allocation of managerial attention, influences the perception of sustainability barriers, and ultimately ...
Zahra Ahmadi‐Gh +1 more
wiley +1 more source
Decarbonization in Financial Turbulent Times: Global Value Chains and Regulatory Framework
Business Strategy and the Environment, EarlyView.ABSTRACT This study examines how participation in global value chains (GVCs) influences carbon emissions amid financial turbulence, with attention to cross‐country heterogeneity and distributional dynamics. Although existing research has explored trade–environment linkages, limited attention has been given to how GVC integration interacts with ...
Xiaoyong Xu +4 more
wiley +1 more source
Business Strategy and the Environment, EarlyView.ABSTRACT This study examines how environmental regulations can drive technological change, drawing on the innovation systems perspective and the strong Porter hypothesis (SPH). The SPH suggests that well‐designed stringent regulations can foster innovation and enhance firm competitiveness, performance, and survival, yet prior research remains largely ...
Muhammad Zubair Khan +3 more
wiley +1 more source
Decoding the Circular Economy Job Market in the EU: A Quantitative and Comparative Analysis
Business Strategy and the Environment, EarlyView.ABSTRACT The circular economy (CE) is increasingly promoted as a pathway to sustainable development, yet systematic evidence on the structure of the CE labor market remains limited. Little is known about how CE‐related job opportunities are distributed across countries, which job characteristics dominate this market, and how such patterns compare with ...
Pavlos Fafalios +2 more
wiley +1 more source
Business Strategy and the Environment, EarlyView.ABSTRACT The growing frequency of global crises has intensified concerns regarding climate vulnerability and the resilience of global production systems. This study examines the heterogeneous effects of supply chain development and supply chain digitalisation on climate vulnerability across countries, while accounting for institutional and investment ...
Ziwei Li +4 more
wiley +1 more source
Business Strategy and the Environment, EarlyView.ABSTRACT This study examines how geopolitical risk, high‐technology exports and the Paris Agreement shape investment in renewable energy across developed and developing economies. Drawing on structural contingency theory, we conceptualise renewable energy investment as a country‐level response to external contingencies and analyse a global panel of 100
Tianqi Luo +5 more
wiley +1 more source
Medicine AdvancesBackground Soft tissue and extraosseous sarcomas (STS) are rare malignancies of mesenchymal origin characterized by heterogeneous biological behavior, posing substantial diagnostic and therapeutic challenges. In China, the paucity of epidemiological data
Zhaoqi Wu +4 more
doaj +1 more source